Soleus Capital Management »

Rayzebio shares owned by Soleus Capital Management

Quarter-by-quarter ownership of Rayzebio shares owned by Soleus Capital Management from 13F filings

Historical chart of Soleus Capital Management investment in Rayzebio

Tip: Access up to 7 years of quarterly data

All positions including Rayzebio held by Soleus Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Rayzebio by Soleus Capital Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $46M 747k 62.17
2023-09-30 $10M 451k 22.20

More positions owned by Soleus Capital Management

Teva Pharmaceutical Inds Sponsored Ads (TEVA)
United Therapeutics Corporation (UTHR)
GSK Sponsored Adr (GSK)
Rayzebio
Edap Tms S A Sponsored Adr (EDAP)
Organogenesis Hldgs (ORGO)
Humana (HUM)
Celcuity (CELC)
Iradimed (IRMD)
Essa Pharma Com New (EPIX)
SurModics (SRDX)
Hca Holdings (HCA)
Vaxcyte (PCVX)
Neuropace (NPCE)
Nuvalent Inc-a (NUVL)

View all positions for Soleus Capital Management

Top funds holding Rayzebio

Viking Global Investors
venBio Partners
VR Adviser
Wellington Management Company
OrbiMed Advisors
Redmile Group
Samsara BioCapital
Fairmount Funds Management
Cormorant Asset Management
Hillhouse Capital Advisors
Deerfield Management Company
Alliancebernstein
Laurion Capital Management
Soleus Capital Management
Perceptive Advisors

View all funds holding Rayzebio